GHK-Cu + KPV blend: research, legal status and who sells it
This page is information, not medical advice. GHK-Cu + KPV blend is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- GHK-Cu and KPV blend
- Category
- Blend of the copper peptide GHK-Cu and the tripeptide KPV
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $0.411/mg to $1.25/mg, median $0.983/mg across 8 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | Neither GHK-Cu nor KPV is an FDA-approved drug, and no approved product combines them [1]. |
| United Kingdom | No UK-licensed medicine contains either peptide [2][3]. |
| European Union | No medicine containing GHK-Cu or KPV is authorized in the EU, according to EMA's central and Article 57 product data [4][5]. |
| Canada | No product containing GHK-Cu or KPV appears in Health Canada's Drug Product Database [6]. |
| Australia | Neither GHK-Cu nor KPV is named in Australia's Poisons Standard (October 2026), but it lists copper compounds for human use in Schedule 4, except low-strength preparations [7]. |
| Sport (WADA) | Neither GHK-Cu nor KPV is named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [8]. |
We haven't published a full overview of GHK-Cu + KPV blend yet. The legal status table and live prices on this page are current.
GHK-Cu + KPV blend prices: cheapest listings
The five lowest $/mg listings out of 8. See all GHK-Cu + KPV blend prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Nexaph | 45 | Beauty Blend GHK-cu/KPV – 50mg/20mg (10 vials/kit) | 70 mg × 10 | $288 | $0.411/mg | View | |
| PS Peptides | 22 | GHK-Cu + KPV Blend (1 Vial) – Subscription | 60 mg | $54 | $0.900/mg | View | |
| Puratek Peptides | 63 | 70 mg | $65 | $0.928/mg | View | ||
| Modern Research Peptides | 10 | GHK/KPV Blend 50/10mg | 60 mg | $58 | $0.967/mg | View | |
| EZ Peptides | 75 | GHK-CU + KPV Blend · 60mg (50mg + 10mg) | 60 mg | $60 | $1.000/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "ghk". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "kpv". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026